Browse studies

Find your next paid study

2 recruiting studies matching your filters

Prospective, Single Group, Open-label Multicenter Phase 2 Study With Single-dose Administration of the Optical Imaging Agent FG001 in Subjects With Newly Diagnosed High Grade Glioma Scheduled for Neurosurgical Tumor Resection Under NIR Fluorescence Guidance

This clinical trial aims to determine if FG001 can assist surgeons in identifying the difference between tumor and healthy tissue during surgery in participant…

High-Grade Glioma (WHO III-IV)

Estimated

~$10 – $7,500

FluoGuide A/SNCT07609472

Phase 1

A Phase 1/2 Study of Pegylated Arginine Deiminase (ADI-PEG 20) Plus Radiotherapy (RT) and Temozolomide (TMZ) in Children, Adolescents, and Young Adults With Newly Diagnosed High-grade Glioma (HGG)

This is an open label, intra-patient dose escalation, to evaluate ADI-PEG 20, in combination with Temozolomide (TMZ) and radiation therapy (RT) in children, ad…

GlioblastomaHigh-Grade Glioma (WHO III-IV)High-grade Glioma+2 more

Estimated

~$10 – $7,500

Sabine Mueller, MD, PhDNCT07389278